![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/26/2935864/0/en/ARCA-biopharma-Provides-Update-Regarding-Special-Dividend-Amount-in-Connection-with-the-Proposed-Merger-with-Oruka-Therapeutics.html
https://www.globenewswire.com/news-release/2024/08/23/2935088/0/en/ARCA-biopharma-Announces-1-for-12-Reverse-Stock-Split-in-Connection-with-the-Proposed-Merger-with-Oruka-Therapeutics.html
https://www.globenewswire.com/news-release/2024/08/01/2923246/0/en/ARCA-biopharma-Announces-Second-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/04/25/2870091/0/en/ARCA-biopharma-Announces-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/04/03/2856818/0/en/ARCA-biopharma-and-Oruka-Therapeutics-Announce-Merger-Agreement.html
https://www.biopharmadive.com/news/arca-oruka-paragon-biotech-reverse-merger/712157/
https://www.globenewswire.com//news-release/2024/02/01/2822487/0/en/ARCA-biopharma-Announces-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2023/10/18/2762764/0/en/ARCA-biopharma-Announces-Third-Quarter-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2023/07/21/2709125/0/en/ARCA-biopharma-Announces-Second-Quarter-2023-Financial-Results.html